D-011-2014 Class II Terminated

Recalled by Greenstone Llc — Peapack, NJ

FDA drug recall D-011-2014 was initiated by Greenstone Llc on Sep 4, 2013 and is designated Class II. Reason for recall: Marketed without an Approved NDA/ANDA: This recall is being initiated because of changes to the dissolution profile in distributed lots resulting from a manufacturing site change. There is currently… The recall status is terminated (terminated Apr 13, 2017). Affected quantity: 4848 bottles.

Recall details

Product Type
Drugs
Report Date
Nov 27, 2013
Initiation Date
Sep 4, 2013
Termination Date
Apr 13, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4848 bottles

Product description

Spironolactone tablets, USP 50 mg, Rx only, 100 count bottle, Distributed By: Greenstone LLC, Peapack, NJ 07977, NDC: 59762-5012-1

Reason for recall

Marketed without an Approved NDA/ANDA: This recall is being initiated because of changes to the dissolution profile in distributed lots resulting from a manufacturing site change. There is currently no approved application supporting the alternate manufacturing site.

Distribution pattern

Nationwide and Puerto Rico

Code information

Lot #: V121211, Exp 03/31/2017

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-011-2014
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-011-2014. Report a data issue: hello@regdatalab.com.